Skip to content
10-Q

Quarterly Report

Dimension Therapeutics, Inc.

0001564590-17-010065

← back to feed
Filed
May 10, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2017 · May 3, 2017 25.04M sh
Capex Q1 2017 · Mar 31, 2017 $24K
Capex Q1 2017 · Mar 31, 2016 $544K
Cash And Equivalents Q1 2017 · Mar 31, 2017 $24.04M
Cash And Equivalents Q1 2017 · Dec 31, 2016 $30.23M
Cash And Equivalents Q1 2017 · Mar 31, 2016 $117.03M
Cash And Equivalents Q1 2017 · Dec 31, 2015 $127.05M
Stockholders Equity Q1 2017 · Mar 31, 2017 $47.49M
Stockholders Equity Q1 2017 · Dec 31, 2016 $59.94M
Current Liabilities Q1 2017 · Mar 31, 2017 $17.39M
Current Liabilities Q1 2017 · Dec 31, 2016 $20.64M
Total Liabilities Q1 2017 · Mar 31, 2017 $30.74M
Total Liabilities Q1 2017 · Dec 31, 2016 $33.92M
Current Assets Q1 2017 · Mar 31, 2017 $70.14M
Current Assets Q1 2017 · Dec 31, 2016 $85.32M
Total Assets Q1 2017 · Mar 31, 2017 $78.23M
Total Assets Q1 2017 · Dec 31, 2016 $93.87M
Sga Expense Q1 2017 · Mar 31, 2017 $3.43M
Sga Expense Q1 2017 · Mar 31, 2016 $2.94M
Rd Expense Q1 2017 · Mar 31, 2017 $13.71M
Rd Expense Q1 2017 · Mar 31, 2016 $8.81M
Net Income Q1 2017 · Mar 31, 2017 −$13.49M
Net Income Q1 2017 · Mar 31, 2016 −$9.51M
Operating Income Q1 2017 · Mar 31, 2017 −$13.53M
Operating Income Q1 2017 · Mar 31, 2016 −$9.54M
Revenue Q1 2017 · Mar 31, 2017 $3.62M
Revenue Q1 2017 · Mar 31, 2016 $2.21M